Rates of distant metastasis and mortality were found to be higher
among breast cancer patients with hormone receptor (HR)-negative, HER2-negative
disease than other cancer types, in a review of physician-reported clinical
information from the Optum Oncology Management Registry (Cancer Res 2017;77[4 suppl]:Abstract P5-08-15).
Presenting their findings at the 2016 San Antonio Breast Cancer Symposium, the investigators identified 6,881 patients 18 years of age or older with early-stage breast